Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.
about
Preclinical rheumatoid arthritis (autoantibodies): an updated reviewFeatures of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritisPreclinical rheumatoid arthritis: identification, evaluation, and future directions for investigationSerum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitisAtherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness.Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritisThe number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent mannerMonocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women.Environmental and gene-environment interactions and risk of rheumatoid arthritis.Strategies to predict rheumatoid arthritis development in at-risk populations.Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis.Urinary interleukin-6 as a predictor of radiographic progression in rheumatoid arthritis: A 3-year evaluation.Monocyte chemoattractant protein-1 (MCP-1): an overviewCan rheumatoid arthritis be prevented?Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.Cardiovascular risk in juvenile idiopathic arthritis.Defining populations at risk of rheumatoid arthritis: the first steps to prevention.Reliable and cost-effective serodiagnosis of rheumatoid arthritis.Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients.Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.IFNβ autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages.Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunityThe preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?Resveratrol lowers synovial hyperplasia, inflammatory markers and oxidative damage in an acute antigen-induced arthritis model.Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: A prospective observational study.Survivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA-Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA
P2860
Q26863441-CC0498CD-AF08-46AE-9130-C9A3DCCD8063Q33667747-1786F8F3-8EC8-44B1-BA4E-13BE276A9F13Q33890221-08A2B78E-D3E3-436A-BA0C-852B89E22B45Q34069262-5BCE0F40-1C1A-4652-9ED2-FD81E29B7239Q34153114-23A203BC-76CA-4923-A891-2AFF6C1377CDQ34166023-3795A7B9-67A6-4AFD-B61C-168DE1017868Q34290839-DBE25AF8-DE78-4924-B201-C33628B69157Q34307377-135435C0-08D4-41B2-BA79-6EDB444FA503Q35983908-C8159F52-59A9-4919-A127-2F7DB5C1C750Q36110733-CF80F96C-2A98-44CC-BED5-FC4166582418Q36366153-EA0C88CE-114F-4662-AD0D-676230655C6BQ36960532-F1643DC0-EDB9-4EC4-A24D-E01C403E93CAQ37330396-DF62CB59-244F-4214-B39D-6698F82F9467Q37481208-9B37E218-A7B5-4B12-9107-5BCC7B6F4608Q37589108-58CF88F7-A27A-4579-B493-547B3EE23B26Q37782589-B7BA408E-86EA-4B8D-B940-E775B4E60453Q38036102-F2BBFC0E-8C6B-483C-A19B-243B6ED5DDFBQ38090373-825FB478-56D0-4CD8-B9DF-208469662A14Q38220638-5A5DB23E-4E1C-4742-8E3D-0D778D482CF0Q38726475-B74F2A97-80BA-46E9-9FA2-23AA6AD11E46Q38995539-7DF5CD98-9424-4BCD-A6AB-BBA7F1686845Q40573679-250EF6DE-A6AE-4D31-B81E-7515F566646AQ40738275-8B90FAB7-E37F-4606-AD18-D7C13371B6DBQ40746700-6B2A394F-56FB-4823-8F00-FD33EFDB730AQ42423867-539C2BFB-6008-496A-A3B5-803C7F400AB6Q44071398-3F3D4FA2-DE30-4325-8054-17DBF8A5D7EFQ50791382-9854A4C7-A128-4D11-BF6E-1771D19D3196Q50879987-CCF671A6-0181-478A-A608-5D4B9884D410Q55241755-213D6FF9-5FB2-4C55-B7C9-16C9FDEE33B4Q58803456-2C61C51E-85E4-4667-B4B9-F5A47A61DAA2
P2860
Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Up regulation of monocyte chem ...... of overt rheumatoid arthritis.
@ast
Up regulation of monocyte chem ...... of overt rheumatoid arthritis.
@en
type
label
Up regulation of monocyte chem ...... of overt rheumatoid arthritis.
@ast
Up regulation of monocyte chem ...... of overt rheumatoid arthritis.
@en
prefLabel
Up regulation of monocyte chem ...... of overt rheumatoid arthritis.
@ast
Up regulation of monocyte chem ...... of overt rheumatoid arthritis.
@en
P2093
P2860
P356
P1476
Up regulation of monocyte chem ...... of overt rheumatoid arthritis.
@en
P2093
A Tarkowski
S Rantapää-Dahlqvist
P2860
P304
P356
10.1136/ARD.2006.057331
P407
P577
2006-06-01T00:00:00Z